Mostrando 2 resultados de: 2
Is “leptin resistance” another key resistance to manage type 2 diabetes?
ReviewAbstract: Although novel pharmacological options for the treatment of type 2 diabetes mellitus (DM2) have beenPalabras claves:Adipokines, DIABÉTES, Hyperleptinemia, Insulin Resistance, leptin, Leptin resistance, obesityAutores:Chávez-Castillo M., Cristobal Ignacio Espinoza Díaz, Dávila L.C.A., D’marco L., González M.C., Herazo Y., Nava M., Ortega A., Pérez J.L., Rojas M., Rojas-Gómez D.M., Rojas-Quintero J., Salazar-Vílchez J., Valmore BermúdezFuentes:googlescopusThe A54T polymorphism in the FABP2 gene and its relationship with obesity
ArticleAbstract: Introduction: Obesity is a complex, multifactorial, and mostly preventable disease affecting, alongPalabras claves:cardiovascular diseases, FABP2, Mutations, obesity, polymorphism, Type 2 Diabetes mellitusAutores:Cano-Ponce C., Carem Prieto, Diaz M.P., Durán P., González M.C., Maritza Torres, Pérez J.L., Rina Ortiz, Rojas M., Valmore Bermúdez, Wilson SigüenciaFuentes:scopus